Vita 34 AG (XTER:V3V) YoY EBITDA Growth : 48.94% (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vita 34 AG's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 48.94%.

Vita 34 AG's EBITDA per Share for the three months ended in Sep. 2023 was €0.14.

Vita 34 AG YoY EBITDA Growth Historical Data

The historical data trend for Vita 34 AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG YoY EBITDA Growth Chart

Vita 34 AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

110.74

33.47

-8.53

-86.91

-798.75

Vita 34 AG Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial															-74.73	-643.66	141.67	221.62	48.94

Vita 34 AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vita 34 AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-1.118	-	0.16)	/	\| 0.16 \|
=	-798.75 %

Vita 34 AG's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(0.14	-	0.094)	/	\| 0.094 \|
=	48.94 %

Vita 34 AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita 34 AG (XTER:V3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

V3V:Germany V3V:Germany V3V:Germany

Address

Deutscher Platz 5a, Leipzig, DEU, D-04103

Website

https://www.vita34.de

Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Executives

Jakub Julian Baran	Member of the Management Board
Dr. Alexander Granderath	Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines